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Abstract
For more than a decade, machine learning (ML) and deep learning (DL) techniques have
been a mainstay in the toolset for the analysis of large amounts of weakly correlated or
high-dimensional data. As new technologies for detecting and measuring biochemical
markers from bodily fluid samples (e.g., microfluidics and labs-on-a-chip) revolutionise
the industry of diagnostics and precision medicine, the heterogeneity and complexity of
the acquired data present a growing challenge to their interpretation and usage. In this
chapter, we attempt to review the state of ML and DL fields as applied to the analysis of
liquid biopsy data and summarise the available corpus of techniques and methodologies.
Keywords: machine learning, deep learning, data analysis, biomarker detection,
automated discovery, literature review
1. Introduction
Biological and medical sciences are becoming increasingly data-rich and information-
intensive. This tendency, along with the growing availability of such data, provides a better
understanding of important questions regarding functions of organisms, causes of diseases,
etc. However, both the inherently massive complexity of biological systems and the high
dimensionality and noisiness of data thus acquired can make it remarkably difficult to cor-
rectly infer such mechanisms. Machine learning (ML) and deep learning (DL) techniques are
quickly becoming highly useful tools for solving difficult problems in biology and medicine by
providing mathematical apparatus for analysing vast amounts of information that would
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otherwise be difficult to process and interpret. Additionally, these fields themselves provide
new challenges for machine learning that can ultimately advance existing ML techniques and
give rise to new ones.
The mutual history of machine learning and biological and medical disciplines is both long
and complex. An early ML technique, the perceptron, was made in attempt to model the
behaviour of biological neurons [1] and was used early on to define the start sites of translation
initiation sequences in E. coli [2], and can be considered the starting point of the entire field of
machine learning. In the last few decades, the power, flexibility, and accessibility of ML and DL
techniques have grown considerably, and it can be expected that they will provide significant
assistance in the discovery and understanding of the mounting volume of biological and
medical data.
In this chapter, we first provide an overview of the commonly usedML and DL techniques and
strategies and outline their broad areas of applicability with regard to processing and analysis
of biological and medical data. Next, we attempt to summarise the available corpus of research
and development concerning the application of ML and DL techniques to the process of
analysis and interpretation of biomedical data, focusing on liquid biopsy analysis, outline
several of the main avenues of such research, and predict the potential improvements and
changes in this highly dynamic and quickly developing field. Expertise in ML is not a prereq-
uisite for this chapter, although we assume basic overall familiarity with the most well-known
ML and DL models, techniques, and methodologies.
2. Machine learning strategies
This overview is limited to classical software-based tools and techniques for brevity’s sake.
Several hardware-based approaches are mentioned in the Future Prospects section.
The ML ecosystem is both extensive and complex [3–5], with many possible ways to subdivide
or classify its members. One frequently used classification scheme outlines two broad groups
of ML algorithms: supervised learning, where the model is presented with both a set of
labelled example inputs and desired outputs (called the training dataset), with the goal to
learn a mapping from inputs to outputs, and unsupervised learning, where no labels are given
to the model, leaving it to learn the input-output mapping in unstructured data. A notable
specific case of supervised learning is reinforcement learning (RL), where training data consists
only of positive (“reward”) and negative (“punishment”) feedback, given according to the
model’s performance in the training environment.
Another informative approach to classifying ML algorithms is based on the desired type of
output of the given model, such as classification (division of the input data into two (binary
classification) or more (multi-label classification) predetermined groups), clustering (similar to
classification but with the groups not known beforehand), dimensionality reduction (simplifi-
cation of high-dimensional input data by mapping them into a lower-dimensional space),
search, etc. Of these, clustering is particularly notable due to its broad and general applicability
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and the wide range of models, methods, and algorithms [6–8] that can be employed to carry
out cluster analysis.
The notion of “cluster” is often not precisely defined and tends to serve as an umbrella term for
various types of data objects, typically groups of data points with small distances (appropri-
ately defined) between group members, higher-density areas of some parameter space, partic-
ular statistical distributions, etc. The desired clustering algorithm, therefore, depends on both
the given data set and the intended application of the returned results. Due to these complica-
tions, clustering, like many other data analysis methods, is typically not fully automated even
within the domain of machine learning but instead tends to partially rely on preprocessing and
initial parameter selection, based on the specifications of the task at hand.
Deep learning is a subclass of machine learning problems, the distinction being based on the
training data representations instead of specific algorithms. Similar to ML in general, deep
learning can be both supervised and unsupervised [9]. Deep learning models tend to be
vaguely similar to information processing patterns in biological brains (and are therefore often
called artificial neural networks), in that they use multiple layers [10] of non-linear processing
units (frequently called “neurons”, even though their similarity to biological neurons is usually
limited) for pattern recognition and transformation, with each successive layer using as inputs
the output from a previous layer, forming a hierarchy of representations and levels of abstrac-
tion. The number of hidden layers of an artificial neural network broadly determines the
“computational power” of the network [11] (Figure 1).
Machine learning models have been applied to a wide variety of fields and problem classes,
including computer vision, natural language processing, machine translation, bioinformatics
and biochemistry [12], with results often similar or superior [13] to those produced by human
domain experts.
Figure 1. The structure of a typical feed-forward deep neural network, with a fully connected input layer I, an unspecified
number of hidden processing layers H, and an output layer O.
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3. Using machine learning techniques in blood tests
3.1. Classifying blood cells with deep convolutional neural networks
An important part of the data acquired by blood tests is the number of white blood cells
(WBCs) or leukocytes, usually differentiated into total and differential WBC count, where the
latter describes the absolute and relative numbers of WBC subtypes (neutrophils, lympho-
cytes, basophils, eosinophils, and monocytes) in the sample. The amount of WBCs in the
sample provides information on the state of the patient’s innate and adaptive immune system,
e.g., a significant changes in the WBC count relative to the patient’s baseline is evidence that
their body is being affected by an antigen, whereas variations in the specific WBC subtypes can
correlate with specific types of antigens or different pathways of immune and inflammatory
reaction. Therefore, detailed measurement and understanding of the WBC counts is an impor-
tant part of the quantitative picture of health and the organism’s general condition.
Traditional methods of estimating the WBC count generally fall into one of two categories—
manual and automated. The historical manual inspection of the blood sample involved
counting the number of cells in a blood sample under a microscope and extrapolating under
the assumption of uniform cell distribution across the entire bloodstream. Automated methods
involve specialised equipment such as Coulter counters [14] or laser flow cytometers [15]
which can provide accurate results and good performance [16] but are generally expensive
and require specialised training to operate.
In this light, the ML-based approach provides a potential improvement over the aforemen-
tioned techniques due to several reasons. First, it requires far less expensive equipment due to
being built around simple imaging solutions. Furthermore, unlike earlier methods, it is able to
provide almost instantaneous results after the initial training stage. Finally, its performance can
be expected to improve over time, in proportion to growing dataset sizes and, being mostly
software-based, it can be expanded and advanced continually and “over the air”, without
requiring extensive changes in the underlying infrastructure.
We illustrate this approach using an example problem provided by Athelas team [17], namely,
binary classification of a stained image of a WBC as either polymorphonuclear or mononu-
clear.1 The training dataset consisted of hand-labelled images of stained WBCs of all given
types in various proportions. Before the dataset could be used, several preprocessing steps
were taken, including removing images with multiple cells and using transformations such as
flips and rotations in order to increase the size and variability of the training dataset. By using
transformed versions of the images, the training dataset size was increased from approxi-
mately 350 to 104.
For the ML model, Athelas team used the LeNet-5 [18] convolutional neural network (CNN) [3,
4, 9] due to its simplicity and availability. The model was tested against a test dataset of 71
images (20% of the original training set and 0.7% of the training set after transformations), with
1
Eosinophils, basophils, and neutrophils are polymorphonuclear, while lymphocytes and monocytes are mononuclear.
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the high accuracy of 98.6%. While the presently used model performs less well (accuracy of
86%) when classifying WBCs into multiple individual type categories as opposed to binary
classification, given the high performance and simplicity of this purely software-based
approach, Athelas team plans to extend it to more complex problems, including datasets contai-
ning other cell types, which could enable faster improvement cycles, increased accessibility, and
better patient outcomes, compared to previously used methods of cell count analysis.
3.2. Using deep neural networks for detection of ageing-related biomarkers
During the last decade, human ageing research has received an increasing amount of main-
stream interdisciplinary attention [19, 20], with an emerging tendency to approach various
aspects of the natural ageing process as potentially treatable conditions.
Insilico team developed a DL system designed to predict human chronological age from
biochemical data obtained from a basic blood test [21], narrowing an extensive set of potential
ageing-related biomarkers to a limited subset of the most salient ones. A dataset of > 6 104
records was used, with each record consisting of a patient’s age, sex, and 46 blood biochemical
markers. The dataset was preprocessed, normalising all blood marker values to 0–1 range, and
then split into training and test datasets with ratio 90:10.
An ensemble of 21 feed-forward deep neural networks (DNNs) was created as the ML model,
with a range of values assigned to DNN parameters such as the number of hidden layers, the
number of processing units per layer, activation function, and optimization and regularisation
methods. The permutation feature importance method [22] was used to evaluate the relative
importance of the various biochemical markers with regard to ensemble accuracy. Batch
normalisation [23] was used to reduce the effects of overfitting and increase the stability of
convergence of the models.
The best results were obtained from a DNN with five hidden layers, using regularised mean
squared error (MSE) function as the loss function, parametric rectified linear unit (PReLU) [24]
activation function in each layer, and AdaGrad [25] optimiser of the loss function. The highest-
scoring DNN performed with 82% ε-prediction accuracy at ε ¼ 10 (i.e., considering the sample
as correctly recognised if the predicted age is 10 years of the true age), out-performing
several classes of competing ML models. Multiple models for combining individual DNNs
into an ensemble (stacking) were evaluated, with the best being the elastic net model [26]. The
most important blood markers were discovered to be albumin, glucose, alkaline phosphatase,
urea, and erythrocyte count.
Insilico team created an online service (http://www.aging.ai) to make the DNN ensemble
available to the general public, allowing patients to use their blood test data to evaluate the
age prediction system and serving as a proof of concept for estimating ageing-related variables
using readily available biochemical data. Additional data sources, including transcriptomic
and metabolomic markers from liquid and individual organ biopsies, as well as imaging data,
are being considered. Insilico team suggests that similar systems could also be developed for
model organisms in order to perform cross-species analysis of individual biological markers
and their importance in predicting both chronological and biological age.
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3.3. Machine learning-based approach to Alzheimer disease biomarker discovery
In their study, Smalheiser team has developed [27] a ML-based model for predicting Alzheimer
disease (AD) status of individual samples with high accuracy, using miRNAs and other small
RNAs extracted from circulating exosomes obtained from liquid biopsy (blood plasma)
samples.
A sample set of N ¼ 70 was used to construct the training dataset consisting of normalised
miRNA expression data across 465 loci. Cross-validation was used in feature selection to
evaluate the impact of values from specific loci as features. The samples were randomly
divided into 7 partitions of 5 positive and 5 negative samples each and cross-validation was
performed on these partitions, using 6 partitions for training and 1 for evaluation. The random
partitioning was repeated 10 times in order to acquire 70 estimate points of the performance
measures of interest, one for each sample in the set. These values were averaged and their
relative performance was assessed using area under the curve of the receiver operating curve
(ROC), Matthews correlation coefficient (MCC) [28], and F1 score.
Smalheiser team evaluated three different ML classifier algorithms—C4.5 decision trees [29]
(using the J48 implementation), support vector machines (SVMs) [30], and adaptive boosting
(AdaBoost) [31]. After selecting 50 most significant features, as per Mann-Whitney U test [32],
the C4.5 classifier produced the best results, based on which it was selected as the feature
selection method. The feature significance was measured by the number of times the given
miRNA locus was used as a node in the decision tree over the 70 runs. The 18 highest-scoring
features were selected to move on to the next step. AdaBoost algorithm was used for the final
feature selection from the set of 18 features, producing an optimised set of 7 features which
were then used with all 70 data samples to produce the final dataset.
The best model used by Smalheiser team was able to correctly classify, on average, 29 out of 35
samples from the AD group and 31 out of 35 samples from the control group, yielding
accuracy in the range of 83–89%. Smalheiser team concluded that ML-based classifiers are able
to produce highly accurate predictions of AD occurrence, using a dataset of only 7 miRNAs
and that integrating exosome miRNA data with other data is likely to further increase perfor-
mance of these models.
3.4. Detection and classification of circulating tumour cells using machine learning
methods
The presence of circulating tumour cells (CTCs) in blood samples indicates the tumour
response to chemotherapeutic drugs and contributes to the mechanism for subsequent growth
of derived tumours (metastasisation) in distant tissues. Evaluation of CTCs can yield the
diagnosis or help to follow the tumour response to chemotherapeutic drugs.
Mao team designed a deep (six layers) CNN for image-based circulating tumour cell detection
with automatically learned network parameters [33]. They used a dataset of 45 phase contrast
microscopy [34, 35] images, of which 35 randomly selected images were used for training and
the remaining 10 for testing the network. The experiment was repeated 5 times in order to
minimise network bias.
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The CNN received normalised 40 40 pixel images as input. They were passed to a layer of 6
convolutional filters with the size of 5 5, followed by a max-pooling layer in order to extract
the local signal in every 2 2 pixel region, defined by the max-pooling function,
zip,q ¼ max
0 ≤m, n ≤ 2
yi2pþm,2qþn
n o
, (1)
where p; qð Þ—pixel coordinates, y—input map, z—output map. This layer was followed by
another convolutional filter layer, consisting of 12 filters, and, subsequently, by another max-
pooling layer. The last layer was fully connected to the output layer by way of dot product
between the weight and input vectors, passed to the sigmoid function which maps the values
to the 1; 1½  range. The filter parameters, network bias terms, and weight matrices were
automatically adjusted by backpropagation with learning rate set to 0:1.
Mao team compared their CNN-based classifier to a simpler, SVM-based method that
depended on hand-crafted feature sets. Using the F-score (harmonic mean of precision and
recall scores) as the comparison metric, they found that, after two rounds of five iterations, the
F-score of the CNN-based classifier was 0.97, by 18.6 points exceeding the F-score (0.784) of the
SVM-based classifier and hand-crafted feature set. They concluded that the CNN-based classi-
fier presents a promising development towards automated CTC detection in images taken
from blood samples, and that the technique could be adapted for use with microfluidics-
based liquid biopsy platforms for early diagnosis and monitoring.
4. Cancer detection and monitoring using neural network-based
methods
4.1. Using artificial neural networks for lung cancer detection and diagnosis
Goryński team describes [36] an artificial neural network (ANN)-based model class used for
early detection and diagnosis of lung cancer. In their study, a dataset consisting of a wide range
of biochemical parameters obtained from blood samples, as well as results from medical
interviews (48 values in total) from 193 patients of mixed age and sex was used to train a
family of 10 multilayer perceptron network (MLP) [3, 4] architectures, using a range of activa-
tion functions (linear, logistic, and tanh) for both hidden and output layers, as well as varying
number of processing units (“neurons”) in the hidden layer and different training algorithms
(gradient descent, Broyden-Fletcher-Goldfarb-Shanno (BFGS) [37], and scaled conjugate gra-
dient (SCG)) [38].
Goryński team found that two of the trained models, named MLP 48–9-22 (trained using BFGS
algorithm and using linear and tanh activation functions for hidden and output layers, respec-
tively) and MLP 48–15-2 (SCG algorithm, logistic and tanh activation functions) gave highly
2
The naming scheme represents the number of “neurons” in the input, hidden, and output layers of the MLP model,
respectively.
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accurate results in terms of inferring the presence or absence of lung cancer from the given set
of variables, with ROC value reaching 99.83%.
Goryński team concluded that these, relatively simple, ANN solutions, while not viable as a full
substitute of expert opinion, are nonetheless efficient in early diagnosis and risk prognosis of
lung cancer and therefore are promising as potential improvements over and additions to the
existing inventory of diagnostic and prognostic methods.
4.2. Mutation prediction and early lung cancer detection in liquid biopsy using
convolutional neural networks
The proliferation of cancer cells is driven by specific somatic mutations in the cancer genome
[39]. To fulfil the high expectations associated with liquid biopsy, such as comprehensive
characteristics of the whole tumour in contrast to limited sampling in the traditional tissue
biopsy, or dynamic assessment during treatment, the somatic mutations must be detected with
high sensitivity and accuracy; limited coverage depth is not sufficient. Kothen-Hill team has
demonstrated a CNN-based classifier system named “Kittyhawk” [40] that enables the detec-
tion of cancer-related mutations even in extremely low variant allele frequencies (VAFs), more
than 2 orders of magnitude lower than is possible with the currently available methods.
For training dataset, whole genome sequencing (WGS) data from 4 non-small cell lung cancer
(NSCLC) patients and 3 melanoma patients were used, with > 1:2 107 reads in total. To
ensure adequate genetic context regardless of variants appearing at the end of the read,
additional bases were added to both ends of the read. Additional bases were also added to
ensure equal read length in cases where a read is shorter than 150 bp.
Kothen-Hill team chose an 8-layer CNN with a single fully connected output layer, similar to
the VGG3 architecture [41], with a perceptive field of size 3 used to convolve the features, based
on results of [42] who showed that the tri-nucleotide context contains distinct mutagenesis-
related signatures. After 2 successive convolutional layers, downsampling by max-pooling
with a receptive field of 2 and a stride of 2 was applied, forcing the model to retain only the
highest-importance features, as per [43]. The output of the last convolutional layer was directly
connected to a fully connected sigmoid output layer for final classification. A logistic regres-
sion layer was used to retain the features associated with the position of the read.
The model was trained using minibatch stochastic gradient decent (SGD) with batch size of
256, initial learning rate of 0.1, and momentum of 0.9, with batch normalisation [23] and a
rectified linear unit (RLU) [44] applied after each convolutional layer.
Kothen-Hill team presents the Kittyhawk architecture as a first of its specific kind, being able to
avoid the information loss associated with similar earlier architectures. To evaluate the perfor-
mance of the model, a test dataset consisting of > 2 105 reads that were split off the training
set of reads from the 4 NSCLC patients was used. Kothen-Hill team found that the model
achieves F1 accuracy of 0.961 when using this test dataset, and 0.92 when using data from an
3
A CNN architecture developed by the Visual Geometry Group at University of Oxford.
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additional independent NSCLC case. When further tested against data from a melanoma case,
F1 accuracy of 0.71 was achieved, indicating that the model had learned specific mutation
patterns associated with NSCLC, as well as a more general pattern associated with both
NSCLC and melanoma.
Kothen-Hill team presents the Kittyhawk CNN model as the first ML architecture designed
specifically for detecting cancer-related mutations in a low allele frequency environment, such
as liquid biopsy and might serve as the foundation for novel early stage cancer detection
techniques that could be used for both screening and prognosis.
4.3. Machine learning and nanofluidics in pancreatic cancer diagnosis
Issadore team has developed a ML-based platform [45] for isolating exosomes from liquid
biopsy samples and, using the RNA inside these exosomes to diagnose pancreatic cancer in
human and murine cohorts.
Using the Exosome Track-Etched Magnetic Nanopore (ExoTENPO) nanofluidics chip developed
as part of the study, Issadore team successfully isolated exosomes from cell cultures, as well as
human and mouse liquid biopsy (blood plasma) samples. Exosomal mRNA was subsequently
extracted and used to develop a predictive panel for pancreatic cancer biomarkers.
Training datasets of 15 mouse and 10 patient profiles, respectively, were created. Linear
discriminant analysis (LDA) [46] was used to identify combinations of mRNA profile that
discriminated between healthy and tumour-bearing samples. The prediction algorithm was
generated by running LDA on the training set, which produced a vector that was used to
calculate a weighted sum such that it maximally separates the control group from the sample
group with tumours. Two independent blinded test sets, mouse (N ¼ 18) and patient (N ¼ 34),
respectively, were used to evaluate the performance of the LDA classifier. Fisher’s exact test
was used to quantify the predictive value of the classifier, yielding P < 0:001.
Although in their study Issadore team focused primarily on the development and evaluation of
the ExoTENPO nanofluidics platform, they conclude that even very simple ML algorithms
such as LDA can produce good quality predictive models for classifying biochemical and
genetic markers and note that more advanced ML solutions could be used in future research
in order to further improve performance.
4.4. Machine learning-based RNA sequencing for multi-class cancer diagnostics
Wurdinger team demonstrated a ML-based approach to sequencing and analysis of mRNAs
obtained from tumour-educated platelets (TEPs) [47] as a tool for accurate tumour diagnosis,
both within a single class and across six different tumour classes.
The initial dataset consisted of blood platelet samples from healthy donors (N ¼ 55) and both
treated and untreated patients with six different tumour types (NSCLC, colorectal cancer,
glioblastoma, pancreatic cancer, hepatobiliary cancer, and breast cancer) in various stages of
advancement and metastasis (N ¼ 228). After the mRNA extraction, amplification, and
sequencing, a set of approximately 5000 different mRNAs was selected for further analysis.
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The accuracy of TEP-based multi-class cancer classification in the training dataset (N ¼ 175)
was estimated, using an SVM algorithm. To cross-validate the SVM for the entire sample set,
leave-one-out cross-validation (LOOCV) method was applied. The percentage of correct pre-
dictions was reported as the accuracy score. The algorithm was performed 175 times, in order
to classify and cross-validate the entire dataset. To determine specific input gene lists for the
algorithm, Wurdinger team performed ANOVA testing. They selected a set of 1072 mRNAs to
use with the training dataset, yielding final accuracy of 96% and ROC value of 0.986. From the
patient cohort, all 39 patients with localised tumours and 33 of the 39 patients with primary
tumours in the CNS were classified as cancer patients.
Wurdinger team concluded that using the SVM classifier with TEP-based data produces high-
accuracy, high-specificity models for liquid biopsy-based diagnostics for several common
cancer types. They expect that using more advanced ML algorithms capable of self-learning
could further improve the performance of these diagnostic models. They also suggest evaluat-
ing systemic factors such as inflammatory diseases and other non-cancerous diseases as poten-
tial factors that can influence the mRNA profile.
5. Using machine learning to accelerate DNA sequencing and biomarker
development
5.1. A supervised machine learning-based approach to DNA sequence analysis
DNA sequencing and sequence analysis is an important task in many scientific and medical
fields that is well-known for being both data-rich and computationally intensive. Memeti &
Pllana describe a ML-based solution for optimised DNA sequence analysis [48, 49]. Their
algorithm leverages the increased performance and parallelisation capabilities of heteroge-
neous (a host central processor (CPU) in combination with a 61-core Intel Xeon Phi co-
processor) multi-core computing platform.
Memeti & Pllana used the widely known Aho-Corasick (AC) algorithm [50] as the basis for
their work, since DNA analysis is a specific case of a string matching problem, where the input
text is the given DNA sequence and the alphabet consists of characters corresponding to the
four nucleotide bases. AC uses finite automata (FA), a simple type of formal machine in the
form of a prefix tree with additional links between internal nodes. These links allow for fast
failure transitions (also known as ε-transitions) between branches of the tree that share a
common prefix, thus avoiding backtracking. A known drawback of the AC algorithm is its
being non-deterministic. Memeti & Pllana solved the non-determinism issue by modifying the
AC finite automaton so that it computes the correct transition for each state, thus eliminating
failure transitions and guaranteeing that every character always has the same number of
operations associated with it.
A boosted decision tree regression-based predictor [51] was used to estimate the execution
time of DNA sequence analysis for both the host CPU and the Intel Xeon Phi co-processor. The
predictor’s output was used to partition the DNA sequence based on the S-factor,
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S ¼
Thost
Tdevice
, (2)
where Thost and Tdevice are execution times for the host CPU and the co-processor, respectively,
and using the partitioning scheme
Ihost ¼ I  Idevice (3)
Idevice ¼
I
Sþ 1
, (4)
where I is the original DNA sequence, Ihost is the part of I analysed by the host CPU, and Idevice
is the part of I analysed by the co-processor.
Memeti& Pllana used the “single instruction, multiple data” (SIMD) parallelism [52] of both the
host CPU and the Xeon Phi co-processor to achieve teraFLOP (1012 floating point operations
per second) performance. For experimental evaluation of their deterministic finite automata
(DFA) algorithm, Memeti & Pllana used reference genomes of human and 11 different animals
from the GenBank sequence database of the National Center for Biological Information, with
the average dataset size of 2043 MB. In total, data from approximately 4000 experiments was
used to train the performance predictor and to evaluate the DFA performance. The DFA
performance was evaluated using different thread affinity modes (compact, balanced, and scat-
ter) and numbers of threads for each of the DNA sequences. The balanced thread affinity mode
evenly distributes the threads among the computing cores, compact mode completely fills a
single core with threads before assigning the remaining threads to the next core, while the
scatter mode distributes threads among the cores in a round-robin sequence.
Memeti & Pllana discovered that the balanced thread affinity mode is overall fastest for all of
the tested DNA sequences, with second best being the scatter mode. The evaluation of DFA
with regard to varying thread counts showed that the algorithm scales well up to approxi-
mately 120 threads, whereas in the 180–240 thread range the performance improvement
becomes modest due to overhead from thread management operations. Performance-wise,
Memeti & Pllana found that the parallel version of DFA running on a heterogeneous platform
has a speed-up from 35:6 up to 206:6, compared to a sequential (single-thread) version
running on the host CPU, with the exact speed-up degree depending on the given host CPU.
Memeti & Pllana. intend to use this work to study and develop highly parallel DNA analysis
solutions on more powerful hardware in the future.
6. Future prospects
While the ML models currently used in liquid biopsy analysis in particular and biological and
medical research in general (typically different classes of neural networks and linear classifiers)
appear to both produce accurate results and show generally high performance, they represent
only a narrow subset of machine learning and artificial intelligence solutions [5]. For instance,
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a potentially valuable research direction might be in the form of highly advanced probabilistic
graphical models [53] augmented with functionality such as one-shot learning [54] and prob-
abilistic program synthesis [55], which could potentially allow researchers to reduce the size of
the commonly massive training datasets required for creating ANN- or DL-based models.
Furthermore, with a single exception, all of the studies reviewed here have been focused on the
performance and accuracy of software ML models, which is currently the predominant class of
machine learning solutions. However, recent advances in general purpose computation using
both graphics processing units (GPUs) and specialised application-specific integrated circuits
(ASICs) tailor-made for machine learning [56] provide a strong case for the exploration and
exploitation of hardware or hybrid ML solutions, as evidenced by, e.g., the results from the
AlphaGo experiments and public performance [57].
7. Conclusions
Liquid biopsy-based approaches open many so far little explored and promising opportunities
for studying and measuring biological and biochemical markers with broad applications for
the monitoring, diagnosis, and prognosis of a large class of diseases and processes. Machine
learning, with its advanced pattern recognition capabilities, will likely play an increasingly
important role in these fields, as the amount and complexity of data produced by scientific and
medical sources already by far exceeds the capacity of unaided human experts and is rapidly
increasing with no foreseeable slowdown.
In addition, machine learning tools form a natural synergy with distributed, highly parallel, or
cloud-based computation solutions, thus easily yielding to collaboration among researchers
and medical professionals from distant locations and involving amounts of data storage and
processing power previously available only on dedicated high performance computing (HPC)
platforms and supercomputers. It is likely that in the near future the importance of
decentralised collaboration will continue to grow, increasing the demand for powerful and
easy to use toolset for analysis and processing of biological data.
Based on these trends, we expect that the next generation of liquid biopsy technologies will
include many types of machine learning as an integral part of their operation and that this
trend could have a significant positive impact on both diagnosis and treatment of patients.
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